BAT's Nicoventures contracts with Consort Medical's Bespak to make nicotine inhalers for harm reduction

[Bill Godshall]

Consort Medical says Bespak signed multi year contract with BAT's Nicoventures to manufacture and assemble nicotine inhalers for use as harm reduction alternatives to cigarettes following regulatory approval
Bosses of King

Bespak, which has a base at Bergen Way in King’s Lynn, will manufacture the inhalation system and have responsibility for the final assembly of the product, including a canister containing an active pharmaceutical ingredient.

Consort Medical said the supply of the product by Bespak would get under way after securing the regulatory green light.

Jon Glenn, chief executive officer of Consort Medical, said: “This is an exciting contract award for Consort Medical, which further demonstrates the full spectrum of the group’s competencies, from product development, through to drug handling and full device assembly.

“The full extent of the revenue opportunity will only become evident following regulatory approval and the product launch. While we do not expect any near-term revenue impact, we are optimistic about the prospects for the product in this very promising market.”

Adrian Marshall, Nicoventures’ managing director, said: “We are delighted to have agreed the contract with Bespak. This takes us closer to our ambition of introducing an innovative, licensed nicotine product as a safer alternative to smoking.”

These guys seem to be confident that UK MHRA's will license nicotine products for THR in the near future.